STOCKHOLM, SWEDEN – March 20, 2026. KDventures AB (Nasdaq Stockholm: KDV) today announces publication of its Annual Report 2025.
The report is now available to download at www.kd-ventures.com
For further information, please contact:
Viktor Drvota, CEO, KDventures AB
Phone: +46 73 982 52 02, e-mail: viktor.drvota@kd-ventures.com
Hans-Christoffer “HC” Toll, CFO, KDventures AB
Phone: +46 70 717 00 41, e-mail: hc.toll@kd-ventures.com
TO THE EDITORS
About KDventures AB
KDventures AB (Nasdaq Stockholm: KDV) is a Nordic investment company specialized in life sciences. The company identifies and invests in innovative pharmaceutical projects and medical technology products originating from leading research institutions in the Nordic region. Through a diversified portfolio across various stages of development, professional due diligence, and active board engagement, KDventures creates value from early research to commercialization. The company offers investors exposure to both listed and private life science projects with significant value growth potential.
For more information, please visit www.kd-ventures.com